Nello Mainolfi - 10 Jan 2022 Form 4 Insider Report for Kymera Therapeutics, Inc. (KYMR)

Role: Chief Executive Officer, Director
Signature: /s/ Bruce Jacobs, as Attorney-in-Fact
Issuer symbol: KYMR
Transactions as of: 10 Jan 2022
Net transactions value: -$2,458,902
Form type: 4
Filing time: 12 Jan 2022, 18:30:12 UTC
Previous filing: 16 Dec 2021
Next filing: 14 Jan 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	KYMR	Common Stock	Options Exercise	$46,727	+22,465	+4.8%	$2.08^*	494,664	10 Jan 2022	Direct
transaction	KYMR	Common Stock	Sale	$392,644	-7,485	-1.5%	$52.46	487,179	10 Jan 2022	Direct	F1, F2
transaction	KYMR	Common Stock	Sale	$569,379	-10,673	-2.2%	$53.35	476,506	10 Jan 2022	Direct	F1, F3
transaction	KYMR	Common Stock	Sale	$228,545	-4,201	-0.88%	$54.40	472,305	10 Jan 2022	Direct	F1, F4
transaction	KYMR	Common Stock	Sale	$5,829	-106	-0.02%	$54.99	472,199	10 Jan 2022	Direct	F1
transaction	KYMR	Common Stock	Options Exercise	$35,200	+16,923	+3.6%	$2.08^*	489,122	11 Jan 2022	Direct
transaction	KYMR	Common Stock	Sale	$533,109	-9,932	-2%	$53.68	479,190	11 Jan 2022	Direct	F1, F5
transaction	KYMR	Common Stock	Sale	$361,582	-6,644	-1.4%	$54.42	472,546	11 Jan 2022	Direct	F1, F6
transaction	KYMR	Common Stock	Sale	$19,103	-347	-0.07%	$55.05	472,199	11 Jan 2022	Direct	F1, F7
transaction	KYMR	Common Stock	Options Exercise	$17,913	+8,612	+1.8%	$2.08^*	480,811	12 Jan 2022	Direct
transaction	KYMR	Common Stock	Sale	$139,877	-2,726	-0.57%	$51.31	478,085	12 Jan 2022	Direct	F1, F8
transaction	KYMR	Common Stock	Sale	$209,210	-4,022	-0.84%	$52.02	474,063	12 Jan 2022	Direct	F1, F9
transaction	KYMR	Common Stock	Sale	$86,457	-1,623	-0.34%	$53.27	472,440	12 Jan 2022	Direct	F1, F10
transaction	KYMR	Common Stock	Sale	$13,007	-241	-0.05%	$53.97	472,199	12 Jan 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	KYMR	Stock Option (Right to Buy)	Options Exercise	$0	-22,465	-3.6%	$0.000000	599,815	10 Jan 2022	Common Stock	22,465	$2.08	Direct	F11
transaction	KYMR	Stock Option (Right to Buy)	Options Exercise	$0	-16,923	-2.8%	$0.000000	582,892	11 Jan 2022	Common Stock	16,923	$2.08	Direct	F11
transaction	KYMR	Stock Option (Right to Buy)	Options Exercise	$0	-8,612	-1.5%	$0.000000	574,280	12 Jan 2022	Common Stock	8,612	$2.08	Direct	F11

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on November 6, 2020.
F2	The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $51.99 to $52.96. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
F3	The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $52.99 to $53.98. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
F4	The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $53.99 to $54.66. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
F5	The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $53.01 to $54.00. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
F6	The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $54.01 to $54.995. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
F7	The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $55.05 to $55.06. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
F8	The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $50.60 to $51.575. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
F9	The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $51.60 to $52.59. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
F10	The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $52.88 to $53.59. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
F11	The shares underlying this stock option vest in forty-eight (48) equal monthly installments following the vesting commencement date of November 14, 2019, subject to the reporting person's continued employment through each vesting date.